CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increased outsourcing of research and development activities
4.1.2. Growing number of clinical trials
4.1.3. Increasing research and development expenditure
4.2. Market Restraints & Challenges
4.2.1. Shortage of skilled professionals
4.2.2. Intense competition in CRO (Contract Research Organization) services market
4.3. Market Opportunities
4.3.1. Growth in biosimilar and biologics markets
4.3.2. Emerging markets
4.3.3. Rising demand for specialised testing services
CHAPTER 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET – BY TYPE
5.1. Clinical research services
5.1.1. Phase I clinical research services
5.1.2. Phase II clinical research services
5.1.3. Phase III clinical research services
5.1.4. Phase IV clinical research services
5.2. Early-phase development services
5.2.1. Chemistry, manufacturing, & control (CMC)
5.2.2. Discovery studies
5.2.3. Preclinical services
5.2.3.1. Pharmacokinetics/pharmacodynamics (PK/PD)
5.2.3.2. Toxicology testing services
5.2.3.3. Other preclinical services
5.3. Laboratory services
5.3.1. Bioanalytical testing services
5.3.2. Analytical testing services
5.3.2.1. Physical characterisation
5.3.2.2. Raw material testing
5.3.2.3. Batch-release testing
5.3.2.4. Stability testing
5.3.2.5. Other analytical testing services
5.4. Consulting services
CHAPTER 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET – BY THERAPEUTIC AREA
6.1. Oncology
6.2. Infectious diseases
6.3. Immunological disorders
6.4. Central nervous system disorders
6.5. Cardiovascular diseases
6.6. Respiratory disorders
6.7. Diabetes
6.8. Others
CHAPTER 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET – BY END USER
7.1. Pharmaceutical & biopharmaceutical companies
7.2. Medical device companies
7.3. Academic institutes
CHAPTER 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET - COMPANY PROFILES
9.1. IMS Holdings, Inc.
9.2. LabCorp
9.3. PAREXEL International
9.4. PRA Health Sciences
9.5. Pharmaceutical Product Development LLC.,
9.6. ICON PLC
9.7. Syneos Health
9.8. WuXi AppTec Group
9.9. Charles River Laboratories
9.10. MeDPAce Holdings
9.11. SGS S.A
9.12. Envigo Corporation
9.13. MPI Research Inc.
9.14. Piramal Pharma Solutions
9.15. Ash Stevens Inc.
9.16. IQVIA
CHAPTER 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES
MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
